Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03791398 |
Title | BrUOG 379 Phase Ib/II Trial ONC201 + Nivolumab in MSS mCRC (379) |
Acronym | 379 |
Recruitment | Terminated |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Khaldoun Almhanna |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |